← All trials
NCT05164198
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 15, 2022
- Primary completion
- Oct 31, 2024
- Completion date
- Oct 31, 2024
- First posted
- Dec 20, 2021
- Last posted
- Dec 20, 2021
- Enrollment
- 448
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Hanyang UniversityLead sponsor
- Linical Co., Ltd.Collaborator
- Hanyang UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.